Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter?
Athiththan Yogeswaran, Manuel Jonas Richter, Natascha Sommer, Hossein Ardeschir Ghofrani, Werner Seeger, Henning Gall, Khodr Tello
Eur Respir J, 56 (3) 1901892; 10.1183/13993003.01892-2019
Pulmonary vascular diseases
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Athiththan Yogeswaran, Manuel Jonas Richter, Natascha Sommer, Hossein Ardeschir Ghofrani, Werner Seeger, Henning Gall, Khodr Tello. Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter?. Eur Respir J, 56 (3) 1901892; 10.1183/13993003.01892-2019
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Patient with ankylosing spondylitis and pulmonary hypertension
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Impact of timing on right heart catheterization measurements in pulmonary hypertension
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Right heart catheterisation: best practice and pitfalls in pulmonary hypertension
Source: Eur Respir Rev 2015; 24: 642-652
Is right heart catheterisation still a fundamental part of the follow-up assessment of pulmonary arterial hypertension? The argument against
Source: Eur Respir J, 52 (1) 1800996; 10.1183/13993003.00996-2018
Right heart catheterisation is still a fundamental part of the follow-up assessment of pulmonary arterial hypertension
Source: Eur Respir J, 52 (1) 1800738; 10.1183/13993003.00738-2018
Treatment of right heart failure on pulmonary arterial hypertension: is going left a step in the right direction?
Source: Eur Respir Rev 2009; 19: 4-6
Right heart catheterisation for assessing pulmonary exercise haemodynamics
Source: International Congress 2016 – PG17 Pulmonary haemodynamics during exercise
Left atrial volume to distinguish idiopathic pulmonary arterial hypertension from pulmonary hypertension due to left heart disease
Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension
Noninvasive evaluation of pulmonary artery pressure during exercise: the importance of right atrial hypertension
Source: Eur Respir J, 55 (2) 1901617; 10.1183/13993003.01617-2019
Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update
Source: Eur Respir J, 53 (1) 1801900; 10.1183/13993003.01900-2018
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm
Source: Eur Respir J 2015; 46: 299-302
The association between resting and mild-to-moderate exercise pulmonary artery pressure
Source: Eur Respir J 2012; 39: 313-318
Beta-blockers in pulmonary arterial hypertension: evolving concepts of right heart failure
Source: Eur Respir J 2015; 46: 619-621
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Right heart imaging and failure in pulmonary hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension?
Source: Eur Respir J 2007; 30: 928-936
Right heart failure in pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Imaging right heart failure in pulmonary hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Systemic Coronary Risk Evaluation and pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Right ventricular function changes after therapy in chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension